A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07430306. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multinational, Interventional, 52-week, Open-label, Single-arm Study to Evaluate the Treatment Outcomes of Anifrolumab 120 mg Subcutaneous Once Weekly in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus (SUNFLOWER)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti-malarial, with or without GC; in patients not in LLDAS at enrolment. Patients will be naïve to any prior conventional immunosuppressant including prior biologic therapy at enrolment. The study will also employ a tapering protocol for a systematic approach to GC tapering, seeking to understand better the proportion of patients in remission who can successfully withdraw chronic GC completely.
Study identification
- NCT ID
- NCT07430306
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 245 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2026 (Actual)
- Primary completion
- Jan 26, 2029 (Estimated)
- Completion
- Jan 26, 2029 (Estimated)
- Last update posted
- Nov 13, 2026
2026 – 2029
United States locations
- U.S. sites
- 32
- U.S. states
- 14
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anniston | Alabama | 36207 | Withdrawn |
| Research Site | Birmingham | Alabama | 35233 | Recruiting |
| Research Site | Phoenix | Arizona | 85032 | Recruiting |
| Research Site | Tucson | Arizona | 85748 | Recruiting |
| Research Site | Fontana | California | 92335 | Not yet recruiting |
| Research Site | La Jolla | California | 92037 | Recruiting |
| Research Site | La Palma | California | 90623 | Recruiting |
| Research Site | Menifee | California | 92586 | Recruiting |
| Research Site | San Leandro | California | 94578 | Recruiting |
| Research Site | Temecula | California | 92592 | Recruiting |
| Research Site | Brandon | Florida | 33511 | Not yet recruiting |
| Research Site | Miami | Florida | 33136 | Not yet recruiting |
| Research Site | Miami | Florida | 33145 | Recruiting |
| Research Site | Miami | Florida | 33180 | Suspended |
| Research Site | St. Petersburg | Florida | 33705 | Not yet recruiting |
| Research Site | Willowbrook | Illinois | 60527 | Recruiting |
| Research Site | New Albany | Indiana | 47150 | Recruiting |
| Research Site | Lake Charles | Louisiana | 70605 | Recruiting |
| Research Site | Silver Spring | Maryland | 20904 | Recruiting |
| Research Site | Kansas City | Missouri | 64151 | Recruiting |
| Research Site | West Long Branch | New Jersey | 07764 | Recruiting |
| Research Site | Oklahoma City | Oklahoma | 73104 | Not yet recruiting |
| Research Site | Oklahoma City | Oklahoma | 73116 | Recruiting |
| Research Site | Memphis | Tennessee | 38104 | Not yet recruiting |
| Research Site | Memphis | Tennessee | 38119 | Recruiting |
| Research Site | Austin | Texas | 78745 | Not yet recruiting |
| Research Site | Baytown | Texas | 77521 | Recruiting |
| Research Site | Colleyville | Texas | 76034 | Recruiting |
| Research Site | Edinburg | Texas | 78550 | Recruiting |
| Research Site | Houston | Texas | 77054 | Recruiting |
| Research Site | Sugar Land | Texas | 77479 | Recruiting |
| Research Site | Spokane | Washington | 99204 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07430306, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2026 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.